搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
BioPharma Dive
5 小时
GSK says antibody drug succeeds in testing for chronic nasal condition
The company has set high expectations for depemokimab, which it is also advancing in three other inflammatory diseases, including asthma.
BioPharma Dive
5 小时
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
BioPharma Dive
5 小时
Lundbeck to buy brain drug developer Longboard for $2.6B
The deal would hand Lundbeck a treatment for a series of rare brain disorders that could, by the company's estimates, become a blockbuster product.
BioPharma Dive
5 小时
Pfizer drug for hemophilia approved by FDA
The approval of Hympavzi Friday was a dose of good news for Pfizer, which is dealing with research setbacks and a challenge from an activist investor.
BioPharma Dive
8 小时
From maximizing recruitment to promoting diversity: How to deploy NGS technologies to ...
Learn how the right NGS technology can enhance clinical research while supporting downstream efforts toward global commercialization.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈